Importantly, the downregulation of Nanog abolishes the proliferation of PC3 cells in vitro by non-cytotoxic mechanisms and inhibits the formation of prostatic cancer in vivo by the promotion of a differentiated phenotype with increased formation of adheren junctions [34]. This evidence concerns the gene NANOG and prostate carcinoma.